NBCD A/S

Knee Osteoarthritis

Clinical research is focused on knee osteoarthritis, with attention to symptom burden, especially knee pain and patient-reported outcomes. The sponsor’s activity is centered on therapies and assessments relevant to degenerative joint disease affecting mobility and daily function.

  • Osteoarthritis-related pain
  • Patient-reported symptom assessment
  • Joint function and discomfort

Research interest extends to understanding treatment effects in a condition where pain perception and symptom reporting are central to clinical evaluation.

Analgesic Treatment Evaluation

The sponsor is involved in evaluating analgesic approaches for musculoskeletal pain, including comparison of active pain-relieving therapy with placebo in the context of osteoarthritic symptoms. The therapeutic emphasis is on relief of joint pain and improvement in patient experience.

  • Non-opioid pain management
  • Topical anti-inflammatory therapy
  • Placebo-controlled pain assessment

Interest in this area reflects a focus on clinically meaningful symptom reduction in chronic joint disease.

Placebo Response Assessment

Research activity includes attention to the placebo response in pain studies, with an emphasis on methods that help interpret patient-reported outcomes in knee osteoarthritis. This area is relevant to understanding how subjective symptom reporting influences treatment evaluation.

  • Placebo effect mitigation
  • Patient-reported knee pain
  • Outcome interpretation in pain trials

The sponsor’s interest lies in clarifying treatment-related changes in pain scores within a symptomatic joint disorder.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Diclofenac compared to Placebo for Pain Relief in Adults with Knee Osteoarthritis

    Not recruiting

    1 1 1
    Investigated drugs:
    Denmark